Xu, Lihong <br/><br/>
COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models.  [electronic resource] 

 -  Science translational medicine  Jun 2014 
 - 242ra84 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1946-6242 
<br/><br/><label>Standard No.: </label>10.1126/scitranslmed.3008455  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Axitinib<br/>Carcinogenesis--pathology<br/>Cell Line, Tumor<br/>Clone Cells<br/>Cyclooxygenase 2--metabolism<br/>Cyclooxygenase 2 Inhibitors--pharmacology<br/>Dinoprostone--metabolism<br/>Female<br/>Humans<br/>Imidazoles--pharmacology<br/>Indazoles--pharmacology<br/>Liver Neoplasms--blood supply<br/>Mammary Neoplasms, Experimental--blood supply<br/>Mice<br/>Neoadjuvant Therapy<br/>Signal Transduction--drug effects<br/>Survival Analysis<br/>Vascular Endothelial Growth Factor A--metabolism<br/>Xenograft Model Antitumor Assays